Bornjever Posted - 1 week ago

$ETNB very positive and steady in late stage Nash for liver disease and cardio and metabolic diseases

vinmee Posted - 1 week ago

$ETNB bullish..28pt .. $VKTX

Stormra Posted - 1 week ago

$ETNB ETNB bought me a New Car 16 months ago, Cash. Now I am back in.

Stormra Posted - 1 week ago

$ETNB Why is this not moving? Analyst Price Targets Powered by TipRanks Avg. Price Target $29.80 High $37.00 Low $14.00 In the last 3 months, 6 ranked analysts set 12-month price targets for ETNB. The average price target among the analysts is $29.80. Analysts compare their price target to the current market price of the stock to determine how much potential upside or downside movement there could be in the stock price.

Stock_Titan Posted - 1 week ago

$ETNB 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/ETNB/89bio-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-29pbbfydqba5.html

steven1x Posted - 2 weeks ago

$ETNB https://www.sec.gov/Archives/edgar/data/1423327/000095017024041024/xslF345X05/ownership.xml

insiderbuyingselling Posted - 2 weeks ago

$ETNB new insider selling: 52718 shares. http://insiderbuyingselling.com/?t=ETNB

xyz200 Posted - 2 weeks ago

$ETNB What a spanking...... nice play clovus lol

vinmee Posted - 03/31/24

$ETNB https://www.globenewswire.com/news-release/2024/03/27/2853082/0/en/89bio-Receives-EMA-PRIME-Status-for-Pegozafermin-in-the-Treatment-of-Metabolic-Dysfunction-Associated-Steatohepatitis-MASH-with-Fibrosis-and-Compensated-Cirrhosis.html

Goreburnelli Posted - 03/30/24

@scanningforbiotechstocks whilst i own both stocks, I think the case for $VKTX rests more solely on its obesity use case, not so much on MASH. Reason being that their MASH candidate still is only in Phase 2 (will take another 3 years or so before coming to market), whilst their competition is already in Phase 3. Their biggest competitor isn’t $MDGL, it is guys like $AKRO, $ETNB who will be releasing Phase 3 in 2025. By the time $VKTX MASH candidate comes out in the market, they will have to beat the FGF21 and PPAR drugs (much higher benchmark). $MDGL has already won the MASH race, so they will dominate the market uncontested over the next 3-5 years. Very very good short to mid-term potential. Their financials will be extremely strong (better than what most are projecting) That said, the TAM of obesity is far larger than MASH, so $VKTX does have a far larger upside potential!

valueforme Posted - 03/29/24

$SGMT Tim Walbert joined the Sagimet board of directors not for money. He is doing VERY WELL financially after Horizon M&A - sec.gov/Archives/edgar/data... if interested. Why has he joined? My guess - to structure a big transaction around denifanstat, which is going to happen sooner than later. There is evidence that FASN inhibitors are complimentary to GLP-1 add THRß agonists. And future of MASH is in combo treatments. The valuation gap between SGMT and FGF21 focused $AKRO and $ETNB is way too significant at the moment. SGMT is just 1 year behind on the trials schedule, at the same time EV looks very different (numbers from YCharts): - ENTB ~ 500M - AKRO ~ 1.2B - SGMT ~ 80M Yes, SGMT does not have enough cash to complete phase 3 trials. And this is what Walbert needs to help with - help figure out what to do - partner before phase 3, sell the company, else.

mrmarvyn Posted - 03/28/24

$ETNB currently at $11. PT announced today for $31. I really like that math!!

mrmarvyn Posted - 03/28/24

$ETNB "In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on 89bio, with a price target of $31.00." https://markets.businessinsider.com/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-89bio-etnb-perspective-therapeutics-catx-1033202776

Kelly12 Posted - 03/28/24

$ETNB when is pdufa?

mrmarvyn Posted - 03/27/24

$ETNB ok, thanks for the PR this morning. Let's start the climb back up!

steven1x Posted - 03/27/24

$ETNB https://www.globenewswire.com/news-release/2024/03/27/2853082/0/en/89bio-Receives-EMA-PRIME-Status-for-Pegozafermin-in-the-Treatment-of-Metabolic-Dysfunction-Associated-Steatohepatitis-MASH-with-Fibrosis-and-Compensated-Cirrhosis.html

DonCorleone77 Posted - 03/27/24

$ETNB 89bio receives EMA PRIME status for Pegozafermin 89bio announced that the European Medicines Agency has granted Priority Medicines status to pegozafermin in patients with MASH. The PRIME status was supported by positive data from the Phase 2b ENLIVEN trial of pegozafermin in patients with non-cirrhotic MASH with fibrosis (F2-F3) and MASH with compensated cirrhosis. "The EMA PRIME status further supports pegozafermin's positioning as a leading FGF21 analog for the treatment of MASH, which has demonstrated robust anti-fibrotic and metabolic benefits as seen in our Phase 2b ENLIVEN trial," said Rohan Palekar, Chief Executive Officer of 89bio. "This status recognizes the urgent need for effective treatment options for MASH patients with advanced fibrosis and underscores pegozafermin's potential to address the targeted unmet medical need. We look forward to working closely with regulatory agencies as we continue to advance our Phase 3 clinical development program, ENLIGHTEN..."

Stock_Titan Posted - 03/27/24

$ETNB 89bio Receives EMA PRIME Status for Pegozafermin in the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Fibrosis and Compensated Cirrhosis https://www.stocktitan.net/news/ETNB/89bio-receives-ema-prime-status-for-pegozafermin-in-the-treatment-of-5y80ccdymrj2.html

Mikehunt113 Posted - 03/20/24

$ETNB can we go back to 8.00 again please?

xyz200 Posted - 03/20/24

$ETNB SPANKED. who can stand against the great Lilly

neverbeenwrong Posted - 03/20/24

$LIFE Breaking through and out. $ICU $ETNB $XBI

xyz200 Posted - 03/20/24

$ETNB That clovus dude is amazing, isnt he? I've followed him for about a year now. I have literally made money doing the exact opposite of what this clown says for months. He is literally ALWAYS wrong. And then he posts how he makes too much capital gains lolol. I have never seen anything like it. I mean most of these folks are right sometimes but he is wrong EVERY time, with great precision lol.

mrmarvyn Posted - 03/19/24

$ETNB oh man. Reallly? The 11s? I wanted to be in the 14s with the MDGL news last week. Argh. I guess just wandering around this level for a while....

Jonita Posted - 03/19/24

$ETNB in in in

StupediaTrades Posted - 1 month ago

$ETNB

StupediaTrades Posted - 1 month ago

@vinmee $ETNB i take it you bought at the top of that trap candle

All_just_a_game Posted - 1 month ago

$ETNB $HEPA $MDGL $VKTX Let me try again…the one that filed in Europe and whose MAA filing was accepted by the European Medicines Agency? The one that met BOTH EMA required endpoints?

All_just_a_game Posted - 1 month ago

$ETNB $HEPA $MDGL $VKTX The one that is going to start generating MASH revenue NEXT month and will own the market!!!!! Ok…There can be way more than one for a complex disease like MASH, but we’ll be waiting multiple years to find out.

vinmee Posted - 1 month ago

$ETNB huge buying .. bullish pattern. $HEPA $VKTX $MDGL $MRNA

rencofilstat Posted - 1 month ago

$MDGL which company's drug has superior efficacy? It's hard to tell. /s $HEPA $VKTX $ETNB